6.31
前日終値:
$6.21
開ける:
$6.3
24時間の取引高:
300.81K
Relative Volume:
1.28
時価総額:
$171.31M
収益:
$331.52M
当期純損益:
$-52.69M
株価収益率:
-2.8044
EPS:
-2.25
ネットキャッシュフロー:
$-14.47M
1週間 パフォーマンス:
+4.99%
1か月 パフォーマンス:
+8.05%
6か月 パフォーマンス:
-22.29%
1年 パフォーマンス:
-21.42%
Inogen Inc Stock (INGN) Company Profile
Compare INGN vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
INGN
Inogen Inc
|
6.31 | 168.59M | 331.52M | -52.69M | -14.47M | -2.25 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-16 | 開始されました | B. Riley Securities | Buy |
| 2025-05-22 | アップグレード | Needham | Hold → Buy |
| 2024-02-15 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2023-08-08 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2023-07-14 | ダウングレード | Needham | Buy → Hold |
| 2023-01-17 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2021-12-09 | アップグレード | Needham | Hold → Buy |
| 2021-11-02 | アップグレード | JP Morgan | Underweight → Neutral |
| 2021-08-05 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-06-04 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2020-12-14 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-23 | ダウングレード | Needham | Buy → Hold |
| 2020-05-06 | 繰り返されました | Needham | Buy |
| 2019-11-06 | アップグレード | Needham | Hold → Buy |
| 2019-09-13 | 繰り返されました | Piper Jaffray | Overweight |
| 2019-08-08 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2019-08-08 | ダウングレード | Stifel | Buy → Hold |
| 2019-08-07 | ダウングレード | Needham | Buy → Hold |
| 2019-06-28 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-05-08 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2019-05-08 | 繰り返されました | Needham | Strong Buy |
| 2019-02-27 | 繰り返されました | Needham | Strong Buy |
| 2018-11-20 | アップグレード | Needham | Buy → Strong Buy |
| 2018-11-07 | 繰り返されました | Needham | Buy |
| 2018-09-10 | ダウングレード | Needham | Strong Buy → Buy |
| 2018-08-22 | 再開されました | Stifel | Buy |
| 2018-08-08 | 繰り返されました | Needham | Strong Buy |
| 2018-06-06 | 開始されました | KeyBanc Capital Mkts | Sector Weight |
| 2018-05-01 | 繰り返されました | Needham | Strong Buy |
| 2018-02-28 | 繰り返されました | Needham | Strong Buy |
すべてを表示
Inogen Inc (INGN) 最新ニュース
Inogen Earnings Call Shows Turnaround Amid Mixed Headwinds - TipRanks
[Form 4] Inogen Inc Insider Trading Activity - Stock Titan
Inogen (NASDAQ: INGN) EVP reports RSU grant, vesting and tax disposals - Stock Titan
Inogen (INGN) CCO reports RSU vesting and 20,000-unit grant - Stock Titan
Inogen (INGN) EVP Kevin P. Smith reports RSU grants and tax share withholding - Stock Titan
Inogen (NASDAQ: INGN) CFO logs RSU vesting, share tax withholdings - Stock Titan
Inogen (INGN) CEO receives 90,000 RSU grant and reports tax share withholdings - Stock Titan
INGN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Revenue Check: Whats the beta of Inogen Inc stock2025 Retail Activity & Growth Focused Investment Plans - baoquankhu1.vn
What’s the beta of Inogen Inc. stock2025 Price Momentum & Daily Price Action Insights - mfd.ru
Inogen (NASDAQ: INGN) outlines 2025 revenue mix and respiratory growth strategy - Stock Titan
Inogen, Inc. (NASDAQ:INGN) Q4 2025 Earnings Call Transcript - Insider Monkey
Inogen Stock Dips Despite Q4 Earnings Beat, Revenues Up Y/Y - sharewise.com
Risk Report: How do insiders feel about Inogen IncWeekly Trade Analysis & Risk Controlled Daily Plans - baoquankhu1.vn
Celebrating 25 Years of Inogen Alliance: A Milestone in Global EHS & Sustainability Leadership - Yahoo Finance
Portfolio Update: Does Inogen Inc have pricing powerPortfolio Profit Report & Low Drawdown Momentum Ideas - baoquankhu1.vn
Inogen, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Inogen authorizes $30 million stock buyback program - Investing.com India
Inogen GAAP net loss hits USD 7.1M in Q4 2025 - Medical Buyer
Inogen Announces $30 Million Share Repurchase Program - BioSpace
Inogen (INGN) Quarterly Losses Persist And Test Bullish Margin Recovery Narratives - Sahm
Inogen Inc earnings beat by $0.07, revenue fell short of estimates - Investing.com Australia
Inogen Inc (INGN) Q4 2025 Earnings Call Highlights: Revenue Grow - GuruFocus
Inogen Q4 Earnings Call Highlights - MarketBeat
Inogen (INGN) Projects Revenue Growth in 2026 Forecast - GuruFocus
Inogen (INGN) Projects Flat Revenue for Q1 2026 - GuruFocus
Inogen authorizes $30 million stock buyback program By Investing.com - Investing.com Australia
Inogen (INGN) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Inogen (INGN) Reports Growth with Positive EBITDA in Q4 - GuruFocus
Inogen Inc (NASDAQ:INGN) Stock Falls on Revenue Miss and Cautious 2026 Outlook - ChartMill
Inogen (INGN) Initiates $30 Million Share Buyback Program - GuruFocus
Inogen, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:INGN) 2026-02-24 - Seeking Alpha
Inogen: Q4 Earnings Snapshot - Barchart.com
Inogen Posts 2025 Results and Launches Share Buyback - TipRanks
Inogen Q4 revenue rises - TradingView
Inogen (NASDAQ:INGN) Releases Earnings Results, Beats Estimates By $0.10 EPS - MarketBeat
Inogen : Supplemental Financials FY 2025 - marketscreener.com
Inogen Announces Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Outlook - marketscreener.com
Inogen, Inc. announces an Equity Buyback for $30 million worth of its shares. - marketscreener.com
Inogen (INGN) lifts 2025 results and OKs $30M share repurchase plan - Stock Titan
Inogen, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2026 - marketscreener.com
Inogen Inc recently announced its revenue forecast for fiscal year 2026. - Bitget
Inogen: Fourth Quarter Financial Overview - Bitget
Inogen launches Aurora CPAP masks in the U.S. - American Academy of Sleep Medicine | AASM
Inogen Inc expected to post a loss of 36 cents a shareEarnings Preview - TradingView
EV Market: Does NVNIW have strong EBITDA marginsExit Point & Reliable Price Breakout Signals - baoquankhu1.vn
Inogen (INGN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Finviz
Will Inogen Inc. stock split attract more investorsWeekly Stock Report & Free Technical Pattern Based Buy Signals - mfd.ru
US Market Wrap: Is Inogen Inc forming a breakout patternWeekly Market Report & Stock Portfolio Risk Control - baoquankhu1.vn
Inogen (INGN) to Release Quarterly Earnings on Tuesday - MarketBeat
Is Inogen Inc. stock vulnerable to regulatory risksJuly 2025 Highlights & Weekly Stock Breakout Alerts - mfd.ru
Inogen Inc (INGN) 財務データ
収益
当期純利益
現金流量
EPS
Inogen Inc (INGN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Yi Boyer Jennifer M | EVP Entrprs Enblmnt, Ch HR Off |
Mar 01 '26 |
Option Exercise |
0.00 |
25,017 |
0 |
33,699 |
| Ramade Gregoire | Chief Commercial Officer |
Mar 01 '26 |
Option Exercise |
0.00 |
13,005 |
0 |
50,251 |
| Smith Kevin P. | EVP, Bus Dev, GC & Sec |
Mar 01 '26 |
Option Exercise |
0.00 |
14,005 |
0 |
28,283 |
| Bourque Michael J. | EVP, CFO & Treasurer |
Mar 01 '26 |
Option Exercise |
0.00 |
42,007 |
0 |
100,949 |
| Smith Kevin Raymond Merrill | CEO and President |
Mar 01 '26 |
Option Exercise |
0.00 |
58,346 |
0 |
147,973 |
| Ramade Gregoire | Chief Commercial Officer |
Dec 01 '25 |
Option Exercise |
0.00 |
31,566 |
0 |
50,189 |
| Smith Kevin Raymond Merrill | CEO and President |
Dec 01 '25 |
Option Exercise |
0.00 |
28,334 |
0 |
100,108 |
| Smith Kevin P. | EVP, Bus Dev, GC & Sec |
Sep 01 '25 |
Option Exercise |
0.00 |
18,135 |
0 |
20,821 |
大文字化:
|
ボリューム (24 時間):